GlassScriptPhysician profile
Julia Kristine Capuson
NPI 1730820168
$515.92
in general payments reported to CMS, 2019-2025
10 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.97 · 2024: $60.71 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $100.93 | 2025 | Dupixent |
| United Therapeutics Corporation | $92.12 | 2023-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $73.63 | 2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $61.36 | 2025 | Keytruda |
| Genzyme Corporation | $52.56 | 2025 | |
| Glaxosmithkline, LLC. | $37.18 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $35.24 | 2025 | Fasenra, Airsupra |
| Verona Pharma, INC. | $26.42 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $21.52 | 2025 | Yupelri |
| Electromed, INC. | $14.96 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Capuson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.